CAS 158697-67-7

Risperidone Difluoroketone (3-(2-(4-(2,4-difluorobenzoyl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)

CAS: 158697-67-7

Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi

Formel: C₂₃H₂₇F₂N₃O₂

Farbe und Form: White Off-White Solid

Molekulargewicht: 415.20713

Ref: 45-1A00600

Risperidone EP Impurity H

CAS: 158697-67-7

Formel: C₂₃H₂₇F₂N₃O₂

Farbe und Form: White To Off-White Solid

Molekulargewicht: 415.48

Ref: 4Z-R-0612

3-[2-[4-(2,4-Difluorobenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one

Kontrolliertes Produkt

CAS: 158697-67-7

Formel: C₂₃H₂₇F₂N₃O₂

Farbe und Form: Neat

Molekulargewicht: 415.48

Ref: 86-MM0491.10

Risperidone EP Impurity H

CAS: 158697-67-7

Formel: C₂₃H₂₇F₂N₃O₂

Molekulargewicht: 415.5

Ref: ST-EA-CP-R15007

3-[2-[4-(2,4-Difluorobenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one

CAS: 158697-67-7

Roflumilast is a drug used to treat chronic obstructive pulmonary disease. It is also used to treat inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. Roflumilast inhibits the enzyme cytochrome P450 in the liver, which is responsible for metabolizing certain drugs and other substances. This inhibition reduces the metabolism of these substances, leading to increased levels of these substances in the body. This can lead to side effects such as nausea, vomiting, dizziness, headache, and itching. Roflumilast also has an anti-inflammatory effect on the intestines by regulating the production of inflammatory cytokines and inhibiting the activity of pro-inflammatory enzymes.

Formel: C₂₃H₂₇F₂N₃O₂

Reinheit: Min. 95%

Molekulargewicht: 415.48 g/mol

Ref: 3D-ID21865